Drug Discovery | Medical XPRT
Articles & Whitepapers
-
Indication selection for anti-PDx combination therapy In collaboration with big pharma - Case Study
The Challenge: One of the most common challenges in immuno-oncology is identifying the indications and patient populations that would benefit from a specific therapy, especially on top of Standard of Care (SOC) treatments. Our platform tackled this challenge of indication prioritization and patient stratification for a combination of a specific target (A) with an anti-PDX drug that one of our ...
-
What is Label-Free Quantification Technique?
The protein label-free quantification technique analyzes protein enzymatic peptide fragments by liquid-quality coupling and compares the signal intensity of the corresponding peptide fragments in ...
News
-
FDA Emerging Technology Program
Broomfield Colorado 6/16/2022. Aktiv Pharma Group (Aktiv) announced today the acceptance of its novel glass-free, film-based flexible primary drug container (PDC) technology for sterile injectables named ARCH, into the US Food and Drug ...
POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as part of Eubiologics’ COVID-19 Vaccine Candidate, EuCorVac-19
Endosomal Signaling Of Delta Opioid Receptors Is An Endogenous Mechanism And Therapeutic Target For Relief From Inflammatory Pain
Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate
CD Genomics Optimized Cancer Hotspot Panel Sequencing Service for Cancer-Related Research
Equipment & Solutions
-
Showcase
Single-use Jumper T Manifolds
ReadyCircuit jumper T manifolds, in 3 port sizes, with C-Flex tubing terminating with ReadyMate single-use connectors.
